Scarica l'app Stockscreener
164.40
2.14%
-3.60
Dopo l'orario di chiusura:
164.40
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$168.00
Aprire:
$167.55
Volume 24 ore:
2.79M
Relative Volume:
1.19
Capitalizzazione di mercato:
$36.54B
Reddito:
$222.29B
Utile/perdita netta:
$1.56B
Rapporto P/E:
25.65
EPS:
6.41
Flusso di cassa netto:
$2.44B
1 W Prestazione:
+0.12%
1M Prestazione:
+6.45%
6M Prestazione:
+39.00%
1 anno Prestazione:
+68.17%
Intervallo 1D:
$162.10
$168.44
Intervallo di 1 settimana:
$162.10
$168.44
Portata 52W:
$93.17
$168.44
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Confronta CAH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
164.40 | 36.54B | 222.29B | 1.56B | 2.44B | 6.41 |
|
MCK
Mckesson Corporation
|
727.74 | 88.11B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
295.33 | 55.56B | 310.23B | 1.69B | 3.58B | 8.62 |
|
HSIC
Henry Schein Inc
|
74.48 | 8.92B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
9.42 | 623.64M | 10.42B | -38.77M | 323.54M | -0.51 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Cardinal Health raises FY 2025 EPS guidance to $8.05-$8.15 amid strong pharma growth and acquisitions - MSN
Cardinal Health (CAH) Affirms Long-Term Growth Raises Outlook - MSN
Deutsche Bank Adjusts Cardinal Health Price Target to $163 From $148 - MarketScreener
Deutsche Bank Raises Price Target on Cardinal Health to $163 From $148, Keeps Hold Rating - marketscreener.com
Cardinal Health (NYSE:CAH) Eyes EPS Growth With IRA Momentum S&P 500 - Kalkine Media
Medical Commode Market Key Players Analysis -Medline - openPR.com
Cardinal Health raises FY25 earnings outlook on investor day - MSN
Cardinal Health (NYSE:CAH) Targets Double-Digit EPS Growth Amid IRA Tailwinds and Healthcare Sector Strength - MSN
Cardinal Health Raises Pharmaceutical Segment Profit Guidance 12-13% for FY25 - cheddar.com
How Is Cardinal Health’s Stock Performance Compared to Other Health Care Service Stocks? - The Globe and Mail
Jefferies Adjusts Price Target on Cardinal Health to $190 From $170, Maintains Buy Rating - marketscreener.com
12 Best Healthcare Stocks to Buy Now - Insider Monkey
TD Cowen Affirms Buy Rating on Cardinal Health - Yahoo Finance
Cardinal Health (CAH) Sees Increased Price Target to $182 by Argus | CAH Stock News - GuruFocus
Cardinal Health price target raised to $185 from $170 at UBS - Investing.com
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Cardinal Health Insiders Sell US$18m Of Stock, Possibly Signalling Caution - Yahoo
Cardinal Health (CAH) Sees Price Target Raised by Morgan Stanley - GuruFocus
Cardinal Health (CAH) Price Target Raised by Citigroup Analyst | CAH Stock News - GuruFocus
Cardinal Health Lifts Earnings Outlook, Impressing Wall Street - Finimize
Cardinal Health (CAH) Sees Price Target Uplift Amid Positive Ind - GuruFocus
Cardinal Health's Guidance Reflects 'Durable Favorable' Backdrop in Drug Distribution Industry, Morgan Stanley Says - marketscreener.com
Cardinal Health (CAH) Receives Upgraded Price Target from BofA A - GuruFocus
Cardinal Health Optimizes Strategy As Earnings Projection Looks Bright - Finimize
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
Cardinal Health Likely Seeing 'More Durable Favorable' Environment as Fiscal 2025 Guidance Raised, Morgan Stanley Says - marketscreener.com
Citius Oncology enters distribution services agreement with Cardinal Health - MSN
Cardinal Health (CAH) Receives Upgraded Price Target from BofA Analyst | CAH Stock News - GuruFocus
Cardinal Health (CAH) Price Target Raised to $170 by Citi Analyst | CAH Stock News - GuruFocus
Incontinence Pads Market Top PlayersCardinal Health Inc., - openPR.com
Evercore ISI Increases Cardinal Health (CAH) Price Target to $18 - GuruFocus
Cardinal Health (CAH) Target Price Raised to $180 by Evercore IS - GuruFocus
US Market Gains As Oracle And Cardinal Health Shine - Finimize
Cardinal Health Inc (CAH) Trading 3.77% Higher on Jun 12 - GuruFocus
Cardinal Health: Strong Outlook and Growing Priorities on Specialty Headline Solid Investor Day - Morningstar
Cardinal Health (CAH) Sets Ambitious Long-Term Growth Targets | - GuruFocus
Cardinal Health boosts profit view banking on specialty drugs unit growth - Reuters
Cardinal Health: Investor Day Highlights Solid Distribution Trend and Strong Long-Term Targets - Morningstar
Cardinal Health (CAH) Updates Fiscal Year 2025 Outlook and Provi - GuruFocus
Cardinal Health (CAH) Adjusts Fiscal Projections and Strategic P - GuruFocus
Transcript : Cardinal Health, Inc.Analyst/Investor Day - MarketScreener
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Chime debut, ConAgra downgrade, Cardinal Health lifts outlook - Yahoo Finance
Cardinal Health (CAH) Target Price Raised to $180 by Evercore ISI | CAH Stock News - GuruFocus
Cardinal Health Lifts Earnings Guidance Amid Strong Growth Outlook - Finimize
Cardinal Health (CAH) Pursues Growth through Strategic Investmen - GuruFocus
Cardinal Health stock soars to all-time high of $158.1 By Investing.com - Investing.com Nigeria
Cardinal Health stock soars to all-time high of $158.1 - Investing.com
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cardinal Health Inc Azioni (CAH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Mayer Jessica L | Chief Legal/Compliance Officer |
Aug 21 '24 |
Sale |
109.39 |
16,573 |
1,812,920 |
75,971 |
1.51%
1.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):